. Author manuscript; available in PMC: 2019 Mar 15.

Published in final edited form as: Clin Cancer Res. 2018 Jan 4;24(6):1305–1314. doi: 10.1158/1078-0432.CCR-17-1929

Table 3.

Most promising EBV-related antibody targets for NPC prediction, identified from custom protein mircroarray

EBV Protein and Mircoarray Sequence	Common Description for EBV Protein	Antibody Type in Risk Score
BZLF1: YP_001129467.1-90855-90724	Zebra (Zta) lytic switch protein	IgG
BORF1: YP_001129451.1-63084-64178	Viral capsid subunit	IgG
BFRF1: YP_001129446.1-46719-47729	Capsid egress protein	IgG
BGLF2: YP_001129486.1-115415-114405	Tegument protein	IgG
BXLF1: YP_001129497.1-133399-131576	Thymidine kinase	IgG, IgA
BRLF1: YP_001129468.1-93725-91908	Rta lytic switch protein	IgA
LF2: YP_001129504.1-151808-150519	LF2 protein	IgG, IgA
BMRF1: YP_001129454.1-67745-68959	Early antigen	IgA
BMRF1: AFY97929.1-67486-68700	Early antigen	IgA
BPLF1: CAA24839.1-71527-62078-2	Tegument protein	IgA